Corteva, Hexagon Bio Form JV to Power Next-Generation Solutions
Warning! Your browser is extremely outdated and not web standards compliant.
Your browsing experience would greatly improve by upgrading to a modern browser.
null

Corteva, Hexagon Bio Form Multi-Million Dollar JV to Power Next-Generation Nature Inspired Solutions

INDIANAPOLIS and MENLO PARK, Calif. – December 16, 2025 – Corteva (NYSE: CTVA), a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover nature-derived medicine, today announced a multi-million-dollar joint venture (JV) to accelerate the development of new crop protection solutions inspired by nature. The JV is the first in the agriculture sector for Hexagon Bio and the first in the pharmaceutical industry for Corteva.

The partnership brings together Corteva’s billion-dollar nature-inspired crop protection franchises and bacterial natural product discovery capabilities with Hexagon Bio’s natural-product discovery platform to advance the companies’ respective pipelines across agriculture and human health.

Read full article

Originally published by Corteva in December 2025.

Related Articles